Explore more publications!

Evergreen State Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Evergreen State Press.

Press releases published on October 16, 2025

Premier Golf Course Property in Sunnyside, WA Now on the Market — Rare Investment Opportunity
New Release: 'Becoming Whole' Offers Breakthrough Shadow Work Method for Spiritual Transformation and Self-Integration'
CORRECTED: Seattle’s Original Romance Bookstore Expands Into Pioneer Square This November
Olalla Recovery Centers Names Derek Murphy as New Executive Director
BirdNote’s Public Radio Show Found to Inspire Millions to Act for Birds
RotoMARKETPLACE Signs Jerico Plastic Industries  As Provider of Bulk Resins to Rotational Molding Members
Seattle U Law, AccessLex Partner to Tackle Central Washington Legal Desert Crisis
C3.ai, Inc. (AI) Hit With Securities Class Action After Shares Crash 25% On Large Revenue Miss -- Hagens Berman
LFMD 11-DAY DEADLINE ALERT: Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman
aTyr Pharma, Inc.’s (ATYR) Failed Drug Trial Spurs Securities Lawsuit -- Hagens Berman
NUTX 5-DAY DEADLINE ALERT: Nutex Health (NUTX) Faces Investor Lawsuit Over Alleged Revenue Inflation Scheme -- Hagens Berman
America’s Car-Mart, Inc. (CRMT) Faces Investor Scrutiny After Significant Q126 Miss, Surprise Spike in Procurement Costs -- Hagens Berman
Stride, Inc. (LRN) Faces Investor Scrutiny Amid Gallup-McKinley’s Complaint to SEC -- Hagens Berman
CarMax, Inc. (KMX) Faces Investor Scrutiny After Unexpected $142 Million Loss Provision Sends Shares Tumbling -- Hagens Berman
Award-Winning Agent Helen Hernandez Archer and The Archer Group Comes Back to eXp Luxury
Pacific AI Becomes a Certified Assurance Resource Provider with the Coalition for Health AI (CHAI)
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions